Clinical trials ought to be delivered pure, without fabrication or falsification.
Editors Khalid S. Khan María Núñez-Núñez
F.A. Butt, M. Nunez-Nunez, B. Juhász, A. Bueno-Cavanillas, K.S. Khan
PubMed: 39657499 DOI: 10.1016/j.semerg.2024.102333
This article captures well the spirit of this peeriodical, and outlines why robust consensus is required to generate meaningful and practicable recommendation documents on the research integrity of clinical trials.